Abramson Cancer Center, University of Pennsylvania

Philadelphia, Pennsylvania 19104

1 studies enrolling now · 15 studies all time

What they study most

B-cell Lymphoma, Breast Cancer, Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma (DLBCL), Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, Head and Neck, Head and Neck Squamous Cell Carcinoma, Incurable Platinum Refractory Germ Cell Tumors, Invasive Breast Carcinoma

Studies at this site

• Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas — Recruiting now
• Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer — Running, not enrolling
• Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) — Running, not enrolling
• Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab — Running, not enrolling
• A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors — Completed
• Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer — Stopped early
• Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis — Stopped early
• Analyses of Human Samples Collected in Clinical Trials — Completed
• CD3/CD28 Bead Activated T-Cells Following Chemo-Immunotherapy in Patients With Chronic Lymphocytic Leukemia — Completed
• Multi-peptide Vaccine With Basilixumab for Breast Cancer — Completed
• Cardiovascular Effects of Sunitinib Therapy (CREST) — Completed
• Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer — Completed
• Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index — Completed
• Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant — Completed
• Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients — Withdrawn before enrolling